Recruiting:Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD): "The purpose of this study is determine the safety, tolerability, and efficacy of 3 doses of lecozotan SR in patients with mild to moderate Alzheimer's Disease over 12 weeks"
Tuesday, July 25, 2006
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment